EUR USD GBP
+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Wound Debridement Products - Global Strategic Business Report

  • ID: 2769230
  • Report
  • October 2016
  • Region: Global
  • 141 Pages
  • Global Industry Analysts, Inc
1 of 4

FEATURED COMPANIES

  • Coloplast A/S (Denmark)
  • Derma Sciences, Inc. (US)
  • MediWound Ltd. (Israel)
  • Misonix, Inc. (US)
  • PuriCore plc (US)
  • Smith & Nephew Plc (UK)
  • MORE
This report analyzes the worldwide markets for Wound Debridement Products in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based on public domain information including company URLs. The report profiles 30 companies including many key and niche players such as -

Advanced Medical Solutions Group plc
Coloplast A/S
Derma Sciences, Inc.
Lohmann & Rauscher GmbH
Misonix, Inc.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Coloplast A/S (Denmark)
  • Derma Sciences, Inc. (US)
  • MediWound Ltd. (Israel)
  • Misonix, Inc. (US)
  • PuriCore plc (US)
  • Smith & Nephew Plc (UK)
  • MORE

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Wound Debridement Products

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW
Wound Debridement
Market Overview
Outlook
Chronic Wounds and Healthcare Burden
Chronic Wounds: The Hard Numbers
Prevalence and Incidence of Wounds
Select Statistics
Table 1: Global Prevalence of Wounds (2015) (includes corresponding Graph/Chart)
Table 2: Global Wound Care Market (2013): Percentage Breakdown of Share by Wound Type (includes corresponding Graph/Chart)
Table 3: Healing Time by Type of Wound (in Days)
Table 4: Incidence of Open Wounds in Select Countries (2013) (includes corresponding Graph/Chart)
Growing Incidence of Hard to Heal Wounds Drives Market for Debridement Products
Maintenance Debridement Sustains Adoption of Debridement Products/Techniques
Competition
Leading Players in the Global Wound Debridement Products Market
Wound Debridement Devices

2. MARKET TRENDS AND DRIVERS
Companies Gear up Focus on Advanced Products to Address Unmet Needs
NexoBrid
EscharEx
CPI Wound Therapy System
Jetox Lavage Systems
Monofilament Polyester Fibre Pads Buoy Growth in Mechanical Debridement Market
Plasma-Mediated Bipolar Radio Frequency Ablation Demonstrates Selective Ablation
Hydrosurgery Emerges as a Safe and Cost Effective Method
Ultrasound Emerges as a Viable Option to Promote Improved Wound Healing
Focus Grows on More Effective and Less Painful Debridement Techniques for Burn Patients
Debridement
An Important Prevention Tool for Chronic wounds in Diabetic Patients
Honey as a Debridement Agent Gains Prominence
Larvae Therapy Re-Emerges as an Effective Debridement Technology
Increasing Focus on Reducing Hospital Stays Lends Traction

3. GENERAL GROWTH DRIVERS
Expanding Aging Population Spurs Demand
Table 5: Elderly Population (60+ Years) as a Percentage of the Total Population: 2012 & 2050 (includes corresponding Graph/Chart)
Table 6: Global Population Statistics for the 65+ Age Group (2015) (includes corresponding Graph/Chart)
Table 7: Life Expectancy at Age 60 and 80 Years
(2010-2015), (2020-2025E) & (2045-2050E) (includes corresponding Graph/Chart)
Rising Prevalence of Diabetes Escalates Incidence of Chronic Wounds
Table 8: Worldwide Prevalence of Diabetes Mellitus by Region: 2013 & 2035 (includes corresponding Graph/Chart)
Table 9: Incidence of Diabetes in Select Countries (2013 & 2035) (includes corresponding Graph/Chart)
Increasing Obesity Levels Underpins Market Growth
Table 10: World Obesity Prevalence (2015 & 2022): Percentage of Obese Population for Leading Ten Countries (includes corresponding Graph/Chart)

4. PRODUCT OVERVIEW
Debridement
Purpose of Debridement
Factors Influencing Debridement Decision
Methods/Techniques of Debridement
Autolytic Debridement
Biologic Debridement
Chemical/Enzymatic Debridement
Mechanical Debridement
Surgical Debridement
Ultrasound
Types of Wounds
Acute Wounds
Surgical Incisions
Burns
Chemical Burns
Electrical Burns
Flash Burns
Radiation Burns
Thermal Burns
Chronic Wounds
Diabetic Ulcers
Venous Ulcers
Pressure Ulcers
Process of Wound Care
Preparation
Controlling Bleeding
Irrigation and Cleaning
Closure
Infection Control
Wound Healing Process
Injury
Inflammatory Response
Characteristics
Coagulation Cascade
Vasodilation
Cellular Activity
Debridement, Cell Growth and Healing
Scarring
Abnormal Scarring
Fetal Wound Healing

5. STRATEGIC CORPORATE DEVELOPMENTS
Lohmann & Rauscher Introduces Debrisoft® Lolly
Misonix Introduces SonicVac based on LFDCU Debridement Technology
Topigenix™ Launches Topigenix™ Wound Care Line
EscharEx® from MediWound Completes Phase II Clinical Trial
Misonix Introduces Sonicone® Ultrasonic Debridement Procedure
Lohmann & Rauscher Launches Debrisoft® Active Monofilament Debriding Device
BioMonde Introduces BioBag for treatment of Chronic Wounds
Oculus Enters into Partnership with Genetix Biotech to Introduce Wound care Products in India
MediWound Commences U.S. Phase 3 Trial with NexoBrid for Treatment of Thermal Burns

6. FOCUS ON SELECT GLOBAL PLAYERS
Advanced Medical Solutions Group plc (UK)
Coloplast A/S (Denmark)
Derma Sciences, Inc. (US)
Lohmann & Rauscher GmbH (Germany)
Misonix, Inc. (US)
PuriCore plc (US)
MediWound Ltd. (Israel)
Smith & Nephew Plc (UK)
Soering GmbH (Germany)
Zimmer Biomet Holdings, Inc. (USA)

7. GLOBAL MARKET PERSPECTIVE
Table 11: World Recent Past, Current & Future Analysis for Wound Debridement Products by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 12: World Historic Review for Wound Debridement Products by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 13: World 14-Year Perspective for Wound Debridement Products by Geographic Region
Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
Current & Future Analysis
Ageing Demographics and Growing Incidence of Chronic Diseases: Major Drivers
Table 14: North American Elderly Population by Age Group (1975-2050) (includes corresponding Graph/Chart)
Table 15: Prevalence of Hard-to-Heal Chronic Wounds in the US (2015): Percentage Breakdown of Share by Type (includes corresponding Graph/Chart)
High Prevalence of Diabetes Drive Growth in Debridement Procedures
Table 16: US Diabetes Statistics (2013): Number of Diabetics by Gender (includes corresponding Graph/Chart)
Table 17: US Diabetes Statistics (2013): Number of Diabetics by Age Group
20-39 Years, 40-59 Years, and 60-79 Years (includes corresponding Graph/Chart)
Table 18: Diabetes Prevalence Statistics in the US by Age Group and Gender (2013 & 2035) (includes corresponding Graph/Chart)
Alarming Rise in Obesity to Drive Demand
Table 19: US Adult Population by Weight Category: 2011-2015 (includes corresponding Graph/Chart)
Table 20: US Adult Obesity Prevalence by Class (2011-2015): Percentage of Adult Population for Class I, Class II and Class III (includes corresponding Graph/Chart)
Medicare Reimbursement
Table 21: 2016 Medicare National Unadjusted Average Payment Rates for Debridement Procedures
Strategic Corporate Developments
Select Players
B.Market Analytics
Table 22: US Recent Past, Current & Future Analysis for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 23: US Historic Review for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

2. CANADA
A.Market Analysis
Current & Future Analysis
Wound prevalence in Canada
A Statistical Review
Table 24: Wound Prevalence in Canada (%) in (2012) (includes corresponding Graph/Chart)
Table 25: Prevalence of Adult Diabetes in Canada by Gender (2010-2014): Number of Adult Males and Females Aged 12 Years and Over Diagnosed with Diabetes (In Thousands) (includes corresponding Graph/Chart)
Table 26: Prevalence of Adult Diabetes in Canada by Age Group (2010-2014): Number of Adult Males and Females with Diabetes by Age Group (In Thousands) (includes corresponding Graph/Chart)
B.Market Analytics
Table 27: Canadian Recent Past, Current & Future Analysis for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 28: Canadian Historic Review for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

3. JAPAN
A.Market Analysis
Current & Future Analysis
B.Market Analytics
Table 29: Japanese Recent Past, Current & Future Analysis for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 30: Japanese Historic Review for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

4. EUROPE
A.Market Analysis
Current & Future Analysis
High Wound Prevalence
A Strong Growth Driver
Table 31: Prevalence of Chronic Wounds in Europe (2015): Percentage Breakdown of Share by Type (includes corresponding Graph/Chart)
Diabetes Statistics in Europe
Table 32: European Diabetes and Population Statistics (2013 & 2035)
Select Players
B.Market Analytics
Table 33: European Recent Past, Current & Future Analysis for Wound Debridement Products by Geographic Region
France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 34: European Historic Review for Wound Debridement Products by Geographic Region
France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 35: European 14-Year Perspective for Wound Debridement Products by Geographic Region
Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
A.Market Analysis
Current & Future Analysis
Wound Management Products
Market Overview
Diabetes Prevalence in Asia
Table 36: Diabetes Prevalence in Asia-Pacific (2015): Age-Adjusted (20-79) Comparative Prevalence of Adult Diabetes for Select Countries (includes corresponding Graph/Chart)
Strategic Corporate Development
B.Market Analytics
Table 37: Asia-Pacific Recent Past, Current & Future Analysis for Wound Debridement Products by Geographic Region
China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 38: Asia-Pacific Historic Review for Wound Debridement Products by Geographic Region
China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 39: Asia-Pacific 14-Year Perspective for Wound Debridement Products by Geographic Region
Percentage Breakdown of Dollar Sales for China, India and Rest of Asia-Pacific Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

6. LATIN AMERICA
A.Market Analysis
Current & Future Analysis
Diabetes Statistics in Latin America
Table 40: Prevalence of Diabetes Mellitus in South & Central America (2013 & 2035): Number of People with DM (in Thousands) in the 20-79 Age Group for 20 Countries in the Region
B.Market Analytics
Table 41: Latin American Recent Past, Current & Future Analysisfor Wound Debridement Products by Geographic Region
Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 42: Latin American Historic Review for Wound Debridement Products by Geographic Region
Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 43: Latin American 14-Year Perspective for Wound Debridement Products by Geographic Region
Percentage Breakdown of Dollar Sales for Brazil and Rest of Latin America Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

7. REST OF WORLD
A.Market Analysis
Current & Future Analysis
Strategic Corporate Development
Select Player
B.Market Analytics
Table 44: Rest of World Recent Past, Current & Future Analysis for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 45: Rest of World Historic Review for Wound Debridement Products Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 30 (including Divisions/Subsidiaries 39)
The United States (26)
Canada (2)
Europe (9)
- Germany (2)
- The United Kingdom (5)
- Rest of Europe (2)
Asia-Pacific (Excluding Japan) (1)
Middle-East (1)

Note: Product cover images may vary from those shown
3 of 4
  • Advanced Medical Solutions Group plc (UK)
  • Coloplast A/S (Denmark)
  • Derma Sciences, Inc. (US)
  • Lohmann & Rauscher GmbH (Germany)
  • Misonix, Inc. (US)
  • PuriCore plc (US)
  • MediWound Ltd. (Israel)
  • Smith & Nephew Plc (UK)
  • Soering GmbH (Germany)
  • Zimmer Biomet Holdings, Inc. (USA)
Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll